Status and phase
Conditions
Treatments
About
The purpose of this study is to evaluate the safety, tolerability, and efficacy of escalating doses of BMS-986463 in participants with select advanced malignant tumors.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria
Exclusion Criteria
Primary purpose
Allocation
Interventional model
Masking
240 participants in 2 patient groups
Loading...
Central trial contact
BMS Study Connect www.BMSStudyConnect.com; First line of the email MUST contain the NCT# and Site#
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal